SCHEMBL268637

SCHEMBL268637

CCCCCCCCCCCCCCCCCC(=O)OC(C)(CCCCCCCC)CCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.52
LMNA P02545 2/20 0.48
PAM P19021 2/20 0.47
MAPT P10636 2/20 0.46
MAPK1 P28482 1/20 0.46
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
TSHR P16473 5/20 0.44
PPARG P37231 6/20 0.43
PPARD Q03181 6/20 0.43
PPARA Q07869 6/20 0.43
HDAC11 Q96DB2 5/20 0.43
GPR84 Q9NQS5 4/20 0.43
ALDH1A1 P00352 2/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
PTPN1 P18031 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17995986 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL5423151 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL16010009 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL16010447 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL21248002 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL14696280 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL14695711 1.00 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL9768575 0.93 LMNA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL9768639 0.93 LMNA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL20918460 0.93 PAM (0.49) DGKALMNAPAMMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673106-A1 COSMETIC COMPOSITION WITH ZINC OXIDE AND BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE L'OREAL (FR) 2026-01-07 EP claimed
WO-2024180130-A1 COSMETIC COMPOSITION WITH ZINC OXIDE AND BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE L'OREAL (FR) 2024-09-06 WO claimed
WO-2024110619-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE VEGETABLE OIL, TRIHYDROXYSTEARIN AND A PIGMENTARY COLORING MATERIAL L'OREAL (FR) 2024-05-30 WO claimed
CN-113194916-B Composition comprising polysaccharide, polyol and specific ester and oil 欧莱雅 2023-10-20 CN claimed
CN-122094651-A Composition comprising particle associates 2026-05-26 CN disclosed
US-20260124130-A1 COMPOSITION COMPRISING A NON-IONIC SURFACTANT, A HYDROCARBON-BASED OIL, A BUTTER AND A WAX SCHEIDLER FOEGLE NATHALIE (FR) 2026-05-07 US disclosed
EP-4734949-A1 COMPOSITION COMPRISING DIFFERENT EXTRACTS L'OREAL (FR) 2026-05-06 EP disclosed
EP-4731310-A1 COMPOSITION WITH CHITOSAN AND A MODIFIED POLYSACCHARIDE L'OREAL (FR) 2026-04-29 EP disclosed
EP-4731166-A1 DISPERSIONS COMPRISING PIGMENTS AND AT LEAST TWO LIPOPHILIC GELLING AGENTS Capsum (FR) 2026-04-29 EP disclosed
EP-4731174-A1 COSMETIC COMPOSITION BASED ON CHITOSAN AND AT LEAST ONE CRYSTALLIZABLE FATTY COMPOUND L'OREAL (FR) 2026-04-29 EP disclosed
US-20260096972-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Fatty Acid Ester of Polyol L'OREAL (FR) 2026-04-09 US disclosed
US-20260096971-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material, At Least Two Polyols, and At least One Anionic Polysaccharide Thickening Agent L'OREAL (FR) 2026-04-09 US disclosed
US-20060275231-A1 Cosmetic composition, a packaging device and a method of application L'OREAL (FR) 2006-12-07 US disclosed
US-20050255068-A9 Cosmetic or dermatological composition comprising at least one gradient copolymer, makeup comprising the cosmetic or dermatological composition and cosmetic method using the composition L'OREAL S.A. (FR) 2005-11-17 US disclosed
US-20050222071-A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) L'OREAL (FR) 2005-10-06 US disclosed
US-6896889-B2 Immediate effect anti-wrinkle composition, based on an aqueous dispersion, of at least one mineral filler L'OREAL (FR) 2005-05-24 US disclosed
US-20050025730-A1 Colored cosmetic composition having soft focus effect L'OREAL (FR) 2005-02-03 US disclosed
US-20050008595-A1 Cosmetic compositions with optical variability L'OREAL S.A. (FR) 2005-01-13 US disclosed
US-20040191199-A1 Cosmetic or dermatological composition comprising at least one gradient copolymer, makeup comprising the cosmetic or dermatological composition and cosmetic method using the composition MOUGIN NATHALIE 2004-09-30 US disclosed
US-20030007985-A1 Immediate effect anti-wrinkle composition, based on an aqueous dispersion, of at least one mineral filler L'OREAL (FR) 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096971-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material, At Least Two Polyols, and At least One Anionic Polysaccharide Thickening Agent GLA, CSGALNACT1, COLGALT1 DGKA 1724/4885LMNA 1075/4885PAM 4123/4885
US-20040191199-A1 Cosmetic or dermatological composition comprising at least one gradient copolymer, makeup comprising the cosmetic or dermatological composition and cosmetic method using the composition KRT18, POLR1C, CUTA DGKA 148/4885LMNA 3662/4885PAM 2939/4885
US-20260124130-A1 COMPOSITION COMPRISING A NON-IONIC SURFACTANT, A HYDROCARBON-BASED OIL, A BUTTER AND A WAX KRT18, CUTA, COL2A1 DGKA 298/4885LMNA 128/4885PAM 3257/4885
US-20260096972-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Fatty Acid Ester of Polyol TAF1, TAF1L, TAF11 DGKA 257/4885LMNA 1192/4885PAM 4007/4885
US-20050222071-A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) DCLRE1B, POLRMT, ADAR DGKA 836/4885LMNA 2861/4885PAM 4433/4885
US-20050255068-A9 Cosmetic or dermatological composition comprising at least one gradient copolymer, makeup comprising the cosmetic or dermatological composition and cosmetic method using the composition KRT18, POLR1C, CUTA DGKA 148/4885LMNA 3662/4885PAM 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.